[HTML][HTML] Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach
DW Group, R Panel… - Journal of gastric …, 2019 - ncbi.nlm.nih.gov
Background Gastric cancer is the most common cancer and the fourth most common cause
of cancer death in South Korea [1]. Despite the large number of gastric cancer patients …
of cancer death in South Korea [1]. Despite the large number of gastric cancer patients …
Surgical management of gastric cancer: a review
GZ Li, GM Doherty, J Wang - JAMA surgery, 2022 - jamanetwork.com
Importance Surgery plays a critical role in the management of all stages of gastric cancer.
Observations For patients with early gastric cancer and low risk of lymph node metastasis …
Observations For patients with early gastric cancer and low risk of lymph node metastasis …
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
More than 1 million (1 089 103) new cases of gastric cancer were estimated globally in
2020, resulting in 768 793 deaths. 1 These burden estimates will continue to increase due to …
2020, resulting in 768 793 deaths. 1 These burden estimates will continue to increase due to …
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
EC Smyth, M Verheij, W Allum… - Annals of …, 2016 - annalsofoncology.org
Almost one million (951 600) new cases of gastric cancer were diagnosed globally in 2012,
resulting in∼ 723 100 deaths [1]. Of these∼ 140 000 cases and∼ 107 000 deaths occurred …
resulting in∼ 723 100 deaths [1]. Of these∼ 140 000 cases and∼ 107 000 deaths occurred …
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
Background Despite its common use in cancer treatment, radiotherapy has not yet entered
the era of precision medicine, and there have been no approaches to adjust dose based on …
the era of precision medicine, and there have been no approaches to adjust dose based on …
[PDF][PDF] Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial
Purpose Chemoradiation with cisplatin 100 mg/m2 given once every 3 weeks is the
standard of care in locally advanced head and neck squamous cell cancer (LAHNSCC) …
standard of care in locally advanced head and neck squamous cell cancer (LAHNSCC) …
[HTML][HTML] A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients …
SH Park, DH Lim, TS Sohn, J Lee, DY Zang, ST Kim… - Annals of …, 2021 - Elsevier
Background Adjuvant chemotherapy and chemoradiotherapy are some of the standards of
care for gastric cancer (GC). The Adjuvant chemoRadioTherapy In Stomach Tumors …
care for gastric cancer (GC). The Adjuvant chemoRadioTherapy In Stomach Tumors …
Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer
Gastric cancer is a major source of global cancer mortality with limited treatment options and
poor patient survival. As our molecular understanding of gastric cancer improves, we are …
poor patient survival. As our molecular understanding of gastric cancer improves, we are …
Medical management of gastric cancer: a 2017 update
N Charalampakis, P Economopoulou… - Cancer …, 2018 - Wiley Online Library
Gastric cancer remains a considerable health burden throughout the world. The Cancer
Genome Atlas (TCGA) analysis has recently unveiled 4 genotypes of gastric cancer with …
Genome Atlas (TCGA) analysis has recently unveiled 4 genotypes of gastric cancer with …
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent …
AE Slagter, EPM Jansen, HWM van Laarhoven… - Bmc Cancer, 2018 - Springer
Background Although radical surgery remains the cornerstone of cure in resectable gastric
cancer, survival remains poor. Current evidence-based (neo) adjuvant strategies have …
cancer, survival remains poor. Current evidence-based (neo) adjuvant strategies have …